Social Acceptability of COVID-19 Vaccines in Pakistan

Sponsor
Islamia University of Bahawalpur (Other)
Overall Status
Completed
CT.gov ID
NCT04727372
Collaborator
(none)
986
4
1
246.5
242

Study Details

Study Description

Brief Summary

Social settings of Pakistan is unique in the sense that it is composed of multilingual, multicultural and different ethnicities. Also their believes and faiths are so unpredictable. It is therefore observed that this social phenomenon affects the acceptability of new things in this area. Polio vaccination has not worked so well in the past. Iodized salt acceptability has also been criticized in the last decades and is a matter of controversy till now. This behavior has also developed before the commencement of vaccination of COVID-19 in Pakistan, as there are many rumors and fears circulating via social media amongst Pakistan. What will be the acceptance rate for this vaccination, the time will decide.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
986 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Social Acceptability of COVID-19 Vaccines in Pakistan: Fear and Social Trends
Actual Study Start Date :
Jan 23, 2021
Actual Primary Completion Date :
Feb 23, 2021
Actual Study Completion Date :
Feb 23, 2021

Arms and Interventions

Arm Intervention/Treatment
Islamabad Group

Individuals residing and surveyed in Islamabad

Other: Questionnaire
A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study

Lahore Group

Individuals residing and surveyed in Lahore

Other: Questionnaire
A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study

Faisalabad Group

Individuals residing and surveyed in Faisalabad

Other: Questionnaire
A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study

Bahawalpur Group

Individuals residing and surveyed in Bahawalpur

Outcome Measures

Primary Outcome Measures

  1. Demographics (Age) [Till 23 February 2021]

    This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their age, their response will be recorded.

  2. Demographics (Weight) [Till 23 February 2021]

    This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their weight and their response will be recorded.

  3. Demographics (Gender) [Till 23 February 2021]

    This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their gender and their response will be recorded.

  4. Demographics (Education) [Till 23 February 2021]

    This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their level of education and their response will be recorded.

  5. Demographics (Family set up) [Till 23 February 2021]

    This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their family set i.e. joint family or separate family and their response will be recorded.

  6. Demographics (Residence) [Till 23 February 2021]

    This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their residence i.e. either in rural area or living in city and their response will be recorded.

  7. Attitude, knowledge and behavior about COVID-19 Vaccine and its acceptance or rejection [Till 23 February 2021]

    As this is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about vaccines, knowledge about vaccines, about corona vaccine specifically, about efficacy of vaccines, about efficacy of COVID-19 vaccine. about acceptance or rejection of vaccine, if they will not have a shot of vaccine then reasons, if they will have shots then reason for vaccination. if they are fear off vaccines then their reasons

Secondary Outcome Measures

  1. Correlation of Age with a particular behavior [Till the end of February 2021]

    Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.

  2. Correlation of Weight with a particular behavior [Till 23 February 2021]

    Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.

  3. Correlation of Gender with a particular behavior [Till 23 February 2021]

    Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.

  4. Correlation of Education level with a particular behavior [Till 23 February 2021]

    Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.

  5. Correlation of Family set up with a particular behavior [Till 23 February 2021]

    Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.

  6. Correlation of Residence with a particular behavior [Till 23 February 2021]

    Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.

  7. Respondents Attitude, knowledge and behavior about COVID-19 Vaccine and its acceptance or rejection [Till 23 February 2021]

    Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination. t-Test will be applied to observe any statistically significant difference between different co-variates

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult

  • Cooperative

  • Willing to participate in study

  • Pakistani citizen

Exclusion Criteria:
  • Minors

  • non-cooperative/unconconcious

  • non-citizen of Pakistan

Contacts and Locations

Locations

Site City State Country Postal Code
1 Islamabad City Islamabad Capital Territory Pakistan 44000
2 Bahawalpur Rural and Urban Areas Bahawalpur Punjab Pakistan 63100
3 Faisalabad city Faisalābad Punjab Pakistan 38000
4 Lahore City Lahore Punjab Pakistan 54000

Sponsors and Collaborators

  • Islamia University of Bahawalpur

Investigators

  • Principal Investigator: Jafir Shirazi, PhD, The Islamia University of Bahawalpur
  • Study Director: Anam Sharmeen, M. Phil, The Islamia University of Bahawalpur
  • Study Chair: Asfa Akbar, M. Phil, The Islamia University of Bahawalpur
  • Study Chair: Fouzia Akbar, M.Phil, The Islamia University of Bahawalpur

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jafir Hussain Shirazi, Lecturer, Islamia University of Bahawalpur
ClinicalTrials.gov Identifier:
NCT04727372
Other Study ID Numbers:
  • Living amongst the fear
First Posted:
Jan 27, 2021
Last Update Posted:
Feb 24, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jafir Hussain Shirazi, Lecturer, Islamia University of Bahawalpur

Study Results

No Results Posted as of Feb 24, 2021